Jeffrey Paley Insider Profile

4 Followers
Jeffrey Paley, Director at Travere Therapeutics, holds 79.66K shares in Avenue Therapeutics (Ticker: ATXI), holds ― shares in Immune Pharmaceuticals (Ticker: IMNPQ), holds 51.66K shares in Travere Therapeutics (Ticker: TVTX). Most recently, Jeffrey Paley Bought ― shares of Avenue Therapeutics on Dec 12, 2018 for an estimated value of 78.50K.
tipranks
Jeffrey Paley

Jeffrey Paley
Travere Therapeutics (TVTX)
Director

Ranked #65,529 out of 78,624 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-49.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
81.89%
18.11%
0.00%
A breakdown of Jeffrey Paley's holdings

Insider Roles

Travere Therapeutics
(TVTX)
Director
Avenue Therapeutics
(ATXI)
Director
Immune Pharmaceuticals
(IMNPQ)
Director
Roles that Jeffrey Paley holds in companies

Most Profitable Insider Trade

Stock:
Avenue Therapeutics
(ATXI)
Rating:Informative Buy
Date:Dec 12, 2018 - Dec 12, 2019
Return:+43.20%
The most profitable trade made by Jeffrey Paley

Jeffrey Paley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Travere Therapeutics
Aug 18, 2014
Director
Informative Sell
245.40K
$1.23M
Immune Pharmaceuticals
Mar 01, 2016
Director
Uninformative Buy
Avenue Therapeutics
Dec 12, 2018
Director
Informative Buy
78.50K
$271.65K
List of latest transactions for each holding click on a transaction to see Jeffrey Paley's performance on stock

Jeffrey Paley insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Paley?
The percentage of profitable transactions made by Jeffrey Paley is 50%.
    What is the average return per transaction made by Jeffrey Paley?
    The average return per transaction made by Jeffrey Paley is -49.10%.
      What stocks does Jeffrey Paley hold?
      Jeffrey Paley holds: TVTX, IMNPQ, ATXI stocks.
        What was Jeffrey Paley’s latest transaction?
        Jeffrey Paley latest transaction was an Informative Buy of $78.50K.
          What was Jeffrey Paley's most profitable transaction?
          Jeffrey Paley’s most profitable transaction was an Informative Buy of ATXI stock on December 12, 2018. The return on the trade was 43.20%.
            What is Jeffrey Paley's role in Travere Therapeutics?
            Jeffrey Paley's role in Travere Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.